Skip to main content
letter
. 2024 Apr 18;37(2):e101501. doi: 10.1136/gpsych-2023-101501

Table 1.

Descriptive characteristics of people with conduct disorder

Individuals diagnosed with conduct disorder
n=71 419 Percentage
Male (vs female) 46 082 64.5%
Racial and ethnic characteristics
Non-Hispanic white 41 248 57.8%
Non-Hispanic black 15 303 21.4%
Hispanic 6965 9.8%
Unknown ethnicity 12 978 18.2%
Unknown race 9993 14.0%
Asian 1049 1.5%
Other race 2994 4.2%
Native Hawaiian or Pacific Islander 438 0.6%
Native American 394 0.6%
Age at time of index (first) diagnosis, in years (SD) 14.7 2.7
Psychiatric diagnoses
Attention-deficit hyperactivity disorder 41 608 58.3%
Generalised anxiety disorder 7341 10.3%
Post-traumatic stress disorder 6981 9.8%
Adjustment disorder 7957 11.1%
Obsessive-compulsive disorder 2682 3.8%
Mood (affective) disorders (major depressive or bipolar disorder) 33 246 46.6%
Schizophrenia-spectrum disorders 3074 4.3%
Personality disorders 3334 4.7%
Impulse control disorders 4998 7.0%
Autism spectrum disorders 8943 12.5%
Intellectual disabilities 5846 8.2%
Any substance use disorder (alcohol, stimulant, cannabis, sedative) 9963 14.0%
Cannabis use disorder 6356 8.9%
Psychotropic medications
Antipsychotics 21 359 29.9%
Risperidone 8088 11.3%
Aripiprazole 7551 10.6%
Quetiapine 4191 5.9%
Olanzapine 3760 5.3%
Haloperidol 3543 5.0%
Ziprasidone 1579 2.2%
Lurasidone 666 0.9%
Psychostimulants 23 256 32.6%
Amphetamine stimulants 12 046 16.9%
Amphetamine Salts 7633 10.7%
Dextroamphetamine 7861 11.0%
Methylphenidate 12 220 17.1%
Dexmethylphenidate 3651 5.1%
Lisdexamfetamine 5738 8.0%
Antidepressants and mood stabilisers
Any selective serotonin reuptake inhibitors 20 468 28.7%
Lithium 613 0.9%
Lamotrigine 2640 3.7%
Carbamazepine 529 0.7%
Valproate 3592 5.0%